Posts in the “Research Research” category:

Blocking the signal: Brain-derived growth factor may lure lung cancer cells to migrate

Posted by Samantha Powell on August 13th, 2014 |

Ninety percent of lung cancer deaths are caused by the tumor’s spread—or metastasis—to other organs. Researchers have now discovered an approach to blocking metastasis in the most common type of lung cancer, adenocarcinoma, that could be added to chemotherapy treatments aimed at shrinking the primary tumor. Kerstin Sinkevicius, a research fellow at Boston Children’s Hospital, […]

Study identifies novel genomic changes in the most common type of lung cancer

Posted by Samantha Powell on July 9th, 2014 |

Researchers from The Cancer Genome Atlas (TCGA) Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer. Knowledge of these genomic changes may expand the number of possible therapeutic targets for this disease and potentially identify a greater number of patients with treatable mutations […]

Lung Cancer Genomic Mapping Yields New Targets in Study

Posted by Samantha Powell on July 9th, 2014 |

Mutations within a small cluster of genes tied to tumor growth are involved in three-quarters of the cases of the most common form of lung cancer, according to a study that could help link treatment to specific genetic flaws. The research is the most comprehensive genomic analysis of adenocarcinoma, a cancer that forms in the […]

Prediction Update: Lung Cancer

Posted by Samantha Powell on July 2nd, 2014 |

In January, we asked, “What will be the most important clinical development in lung cancer in 2014?” Now, at the half-year mark, we return to Peter Mazzone, MD, MPH, of the Cleveland Clinic; Mary E. Reid, MSPH, PhD, of Roswell Park Cancer Institute in Buffalo, N.Y.; Marcelo DaSilva, MD, of Loyola University in Chicago; and […]

Feds fund lung cancer research at New York Medical College

Posted by Samantha Powell on June 30th, 2014 |

New York Medical College in Valhalla has been awarded a $201,250 grant to study lung cancer formation and growth triggered by nickel compounds. The award from the National Institutes of Health was recently announced by U.S. Rep. Nita M. Lowey, the senior Democrat on the House Appropriations Committee from the 17th congressional district in Westchester […]

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

Posted by Samantha Powell on June 23rd, 2014 |

This month, the National Cancer Institute (NCI), along with the FDA, the Southwest Oncology Group (SWOG), several private foundations and five pharmaceutical companies, launched a prospective, biomarker-driven study of new drugs for squamous cell lung cancer. The Lung-MAP trial is remarkable for its collaborative nature, and scope. The study will identify “actionable” molecular abnormalities in […]

Damon Runyon Cancer Research foundation awards $4M to 10 top young clinical investigators

Posted by Samantha Powell on June 23rd, 2014 |

The Damon Runyon Cancer Research Foundation named seven new Damon Runyon Clinical Investigators at its spring 2014 Clinical Investigator Award Committee review. The recipients of this prestigious three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians. Each will receive […]

Johnson & Johnson Innovation Announces Immuno-Oncology Lung Cancer Collaboration with the Dana-Farber Cancer Institute’s Belfer Institute for Applied Cancer Science

Posted by Samantha Powell on June 23rd, 2014 |

Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. today announced a three-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer Institute. Through the collaboration, Janssen scientists will work with the research team at Dana-Farber’s Belfer Institute for Applied Cancer Science to determine the clinical setting for certain immuno-oncology agents in Janssen’s lung cancer discovery […]

A Cure for Lung Cancer? Doctors Hail Incredible Breakthrough With New Drugs

Posted by Samantha Powell on May 17th, 2014 |

Date: 5/17/14 Outlet Full Name: Daily Mail UK Author: Stephen Adams – Scientists are reporting success treating advanced lung cancer with drugs such as nivolumab – The drug helped a quarter of 129 US patients with advanced lung cancer survive two years – Nivolumab is one of a new class of drug, called anti-PD1s […]

Analysis Finds Wide Variation in Lung Cancer Rates Globally

Posted by Samantha Powell on May 16th, 2014 |

Date: 5/16/14 Outlet Full Name: Medical Xpress Author: No author The only recent comprehensive analysis of lung cancer rates for women around the world finds lung cancer rates are dropping in young women in many regions of the globe, pointing to the success of tobacco control efforts. However, rates continue to increase among older […]